Michael A. Scarpone, Daniel Kuebler.
Pilot Study | White Paper
Michael A. Scarpone, D.O. and Dr. Daniel Kuebler investigated if reducing the Marrow Cellution aspiration volume per location would lead to higher stem-/progenitor cell concentrations.
Main finding: “Reducing the aspiration volume per location within the iliac bone from approximately 1ml to ½ml using the Marrow Cellution device significantly improved the cell counts.”
The Marrow Cellution™ System is designed to minimize and eliminate the restrictive limitations associated with “point of care” processing systems which employ inefficient traditional aspiration trocar technology and are regulated as drugs “Advanced Therapies Medicinal Products (ATMP)”. Marrow Cellution™ is a minimally invasive bone/cell enriched autograft access and retrieval system, which does not require additional manipulation or processing, it never leaves the sterile field and provides rich autograft without associated morbidity.
Visit our Marrow Cellution product page